BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 26971848)

  • 1. Somatic and germline mutations in NETs: Implications for their diagnosis and management.
    Minnetti M; Grossman A
    Best Pract Res Clin Endocrinol Metab; 2016 Jan; 30(1):115-27. PubMed ID: 26971848
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Systematic comparison of sporadic and syndromic pancreatic islet cell tumors.
    Erlic Z; Ploeckinger U; Cascon A; Hoffmann MM; von Duecker L; Winter A; Kammel G; Bacher J; Sullivan M; Isermann B; Fischer L; Raffel A; Knoefel WT; Schott M; Baumann T; Schaefer O; Keck T; Baum RP; Milos I; Muresan M; Peczkowska M; Januszewicz A; Cupisti K; Tönjes A; Fasshauer M; Langrehr J; von Wussow P; Agaimy A; Schlimok G; Lamberts R; Wiech T; Schmid KW; Weber A; Nunez M; Robledo M; Eng C; Neumann HP; ;
    Endocr Relat Cancer; 2010 Dec; 17(4):875-83. PubMed ID: 20660572
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Inherited tumor syndromes of gastroenteropancreatic and thoracic neuroendocrine neoplasms].
    Couvelard A; Scoazec JY
    Ann Pathol; 2020 Apr; 40(2):120-133. PubMed ID: 32035641
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Clinical genetics of neuroendocrine tumors].
    Karges W; Adler G
    Med Klin (Munich); 2003 Dec; 98(12):712-6. PubMed ID: 14685672
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A novel germline mutation at exon 10 of MEN1 gene: a clinical survey and positive genotype-phenotype analysis of a MEN1 Italian family, including monozygotic twins.
    Palermo A; Capoluongo E; Del Toro R; Manfrini S; Pozzilli P; Maggi D; Defeudis G; Pantano F; Coppola R; Di Matteo FM; Raffaelli M; Concolino P; Falchetti A
    Hormones (Athens); 2018 Sep; 17(3):427-435. PubMed ID: 30083881
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Molecular genetics of gastroenteropancreatic neuroendocrine tumors.
    Starker LF; Carling T
    Curr Opin Oncol; 2009 Jan; 21(1):29-33. PubMed ID: 19125015
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular genetics of gastroenteropancreatic neuroendocrine tumors.
    Toumpanakis CG; Caplin ME
    Am J Gastroenterol; 2008 Mar; 103(3):729-32. PubMed ID: 18341492
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neuroendocrine neoplasms in the context of inherited tumor syndromes: a reappraisal focused on targeted therapies.
    Ruggeri RM; Benevento E; De Cicco F; Fazzalari B; Guadagno E; Hasballa I; Tarsitano MG; Isidori AM; Colao A; Faggiano A;
    J Endocrinol Invest; 2023 Feb; 46(2):213-234. PubMed ID: 36038743
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Endocrine cancer syndromes: an update.
    Anik A; Abaci A
    Minerva Pediatr; 2014 Dec; 66(6):533-47. PubMed ID: 25243504
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Indications for genetic study in gastro-entero-pancreatic and thoracic neuroendocrine tumors.
    Araujo-Castro M
    Endocrinol Diabetes Nutr (Engl Ed); 2023 Mar; 70 Suppl 1():63-73. PubMed ID: 36396595
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The genetics of neuroendocrine tumors.
    Öberg K
    Semin Oncol; 2013 Feb; 40(1):37-44. PubMed ID: 23391111
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Associated gastroenteropancreatic neuroendocrine tumours to familiar syndromes].
    Lecumberri Pascual E
    Endocrinol Nutr; 2009 Apr; 56 Suppl 2():10-5. PubMed ID: 19627764
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular genetics of neuroendocrine tumors.
    Calender A
    Digestion; 2000; 62 Suppl 1():3-18. PubMed ID: 10940682
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical and prognostic implications of the genetic diagnosis of hereditary NET syndromes in asymptomatic patients.
    Ramundo V; Milone F; Severino R; Savastano S; Di Somma C; Vuolo L; De Luca L; Lombardi G; Colao A; Faggiano A
    Horm Metab Res; 2011 Oct; 43(11):794-800. PubMed ID: 22009375
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Distinct DNA Methylation Signatures in Neuroendocrine Tumors Specific for Primary Site and Inherited Predisposition.
    Tirosh A; Killian JK; Petersen D; Zhu YJ; Walker RL; Blau JE; Nilubol N; Patel D; Agarwal SK; Weinstein LS; Meltzer P; Kebebew E
    J Clin Endocrinol Metab; 2020 Oct; 105(10):3285-94. PubMed ID: 32706863
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pediatric paraganglioma: an early manifestation of an adult disease secondary to germline mutations.
    Mora J; Cascón A; Robledo M; Catala A
    Pediatr Blood Cancer; 2006 Nov; 47(6):785-9. PubMed ID: 16304664
    [TBL] [Abstract][Full Text] [Related]  

  • 17. GEP- NETS UPDATE: Genetics of neuroendocrine tumors.
    Crona J; Skogseid B
    Eur J Endocrinol; 2016 Jun; 174(6):R275-90. PubMed ID: 27165966
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The efficacy of everolimus and sunitinib in patients with sporadic or germline mutated metastatic pancreatic neuroendocrine tumors.
    Nuñez JE; Donadio M; Filho DR; Rego JF; Barros M; Formiga MN; Lopez R; Riechelmann R
    J Gastrointest Oncol; 2019 Aug; 10(4):645-651. PubMed ID: 31392045
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Genetics of neuroendocrine tumours, hereditary tumour syndromes].
    Igaz P
    Orv Hetil; 2013 Sep; 154(39):1541-8. PubMed ID: 24058099
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Genetic testing in multiple endocrine neoplasia and related syndromes.
    Calender A
    Forum (Genova); 1998; 8(2):146-59. PubMed ID: 9666051
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.